Last reviewed · How we verify
Other Pertussis Vaccines
Other Pertussis Vaccines is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently in Phase 2 development. Also known as: DAPTACEL®, Tripedia®, TriHIBit®, Infanrix®.
At a glance
| Generic name | Other Pertussis Vaccines |
|---|---|
| Also known as | DAPTACEL®, Tripedia®, TriHIBit®, Infanrix®, Pediarix® |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents (PHASE3)
- The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) (PHASE4)
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe (PHASE3)
- A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
- An Evaluation of a Dynamic Web-Based Visualization of Community Immunity (NA)
- A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) (PHASE3)
- A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants (PHASE4)
- Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Other Pertussis Vaccines CI brief — competitive landscape report
- Other Pertussis Vaccines updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI
Frequently asked questions about Other Pertussis Vaccines
What is Other Pertussis Vaccines?
Other Pertussis Vaccines is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.
Who makes Other Pertussis Vaccines?
Other Pertussis Vaccines is developed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).
Is Other Pertussis Vaccines also known as anything else?
Other Pertussis Vaccines is also known as DAPTACEL®, Tripedia®, TriHIBit®, Infanrix®, Pediarix®.
What development phase is Other Pertussis Vaccines in?
Other Pertussis Vaccines is in Phase 2.
Related
- Manufacturer: Sanofi Pasteur, a Sanofi Company — full pipeline
- Also known as: DAPTACEL®, Tripedia®, TriHIBit®, Infanrix®, Pediarix®
- Compare: Other Pertussis Vaccines vs similar drugs
- Pricing: Other Pertussis Vaccines cost, discount & access